Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Only Alli Remains After Glaxo’s OTC Transaction With Aspen

23 Apr 2012

• By Dan Schiff

Related Content

GSK Takes Pay-As-You Go Approach In Aspen Branded Generics Deal

28 Jul 2008

Omega Pharma Acquires Six Glaxo OTC Brands, But <em>Alli</em> Lingers

19 Mar 2012

Related Companies

GSK plc

Aspen Pharmacare Holdings Limited

GSK plc

Prestige Consumer Healthcare Inc.

Omega Pharma NV

Additional Topics

Middle East and Africa South Africa Deals Emerging Markets OTC Drugs Consumer

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.